Regressing and progressing metastatic lesions: Resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations

  1. Aptsiauri, N.
  2. Carretero, R.
  3. Garcia-Lora, A.
  4. Real, L.M.
  5. Cabrera, T.
  6. Garrido, F.
Revue:
Cancer Immunology, Immunotherapy

ISSN: 0340-7004

Année de publication: 2008

Volumen: 57

Número: 11

Pages: 1727-1733

Type: Communication dans un congrès

DOI: 10.1007/S00262-008-0532-3 GOOGLE SCHOLAR
La source de données: Scopus